Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$758 Hold
45
– – ﹤0.01% 272
2026
Q2
$828 Hold
45
– – ﹤0.01% 280
2026
Q1
$910 Hold
45
– – ﹤0.01% 266
2025
Q4
$863 Hold
45
– – ﹤0.01% 273
2025
Q3
$1.08K Hold
45
– – ﹤0.01% 245
2025
Q2
$876 Hold
45
– – ﹤0.01% 249
2025
Q1
$579 Hold
45
– – ﹤0.01% 246
2024
Q4
$776 Hold
45
– – ﹤0.01% 269
2024
Q3
$1.02K Hold
45
– – ﹤0.01% 244
2024
Q2
$1.11K Hold
45
– – ﹤0.01% 242
2024
Q1
$1.48K Hold
45
– – ﹤0.01% 252
2023
Q4
$1.64K Buy
+45
New +$1.54K ﹤0.01% 276

Other funds holding ADNT

Birchbrook's ADNT Position: Q3 2026 in Review

Birchbrook held its Adient (ADNT) position steady in Q3 2026 at 45 shares worth $758. The position accounts for ﹤0.01% of the portfolio, ranked #272.

Birchbrook first reported a position in ADNT in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.64K in Q4 2023. 80 funds tracked by Wall St. Rank hold ADNT as of Q3 2026.

  • Birchbrook held 45 shares of Adient worth $758 as of Q3 2026.
  • Birchbrook left its Adient share count unchanged in Q3 2026.
  • Adient made up ﹤0.01% of Birchbrook's portfolio in Q3 2026, its #272 holding.
  • Birchbrook first reported a position in Adient in Q4 2023 and has held it in 12 quarters since.
  • Birchbrook's Adient position peaked at $1.64K in Q4 2023.
  • 80 funds tracked by Wall St. Rank held Adient as of Q3 2026.

Based on Birchbrook's 13F filing for Q3 2026, filed 14 Oct 2026.